Drug resistance is the main obstacle to achieving a cure in many cancer patients. Reactive
oxygen species (ROS) are master regulators of cancer development that act through …

The successful treatment of cancer has significantly improved as a result of targeted therapy
and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire …

Cancer treatment is hampered by resistance to conventional therapeutic strategies,
including chemotherapy, immunotherapy, and targeted therapy. Redox homeostasis …

Elevated levels of reactive oxygen species (ROS) are a hallmark of cancer. Although
increased ROS concentrations play important roles in cancer formation and progression …

Reactive oxygen species (ROS), now appreciated for their cellular signaling capabilities,
have a dual role in cancer. On the one hand, ROS can promote protumorigenic signaling …

Evading persistent drug resistance in cancer and bacteria is quintessential to restore health
in humans, and impels intervention strategies. A distinct property of the cancer phenotype is …

Reactive oxygen species (ROS) are important in regulating normal cellular processes, but
deregulated ROS contribute to the development of various human diseases, including …

Increased reactive oxygen species (ROS) production has been detected in various cancers
and has been shown to have several roles, for example, they can activate pro-tumourigenic …

Drug resistance in cancer is an overwhelming problem, because drug‐resistant cancer cells
are harder to kill with the same drug. The mechanism of drug resistance differs for various …

Cancer development, progression, and metastasis are multistep processes. Accumulating
evidence suggests that reactive oxygen species (ROS) are critically involved in cancer cell …